-
1
-
-
0033135569
-
Glomerulonephritis
-
Couser, W.G. (1999) Glomerulonephritis. Lancet 353, 1509-1515
-
(1999)
Lancet
, vol.353
, pp. 1509-1515
-
-
Couser, W.G.1
-
2
-
-
33645187800
-
Introduction to glomerular disease: Pathogenesis and classification
-
(Johnson, R.J. and Feehally, J., eds), Mosby
-
Johnson, R.J. et al. (2003) Introduction to glomerular disease: pathogenesis and classification. In: Comprehensive Clinical Nephrology (Johnson, R.J. and Feehally, J., eds), pp. 243-253, Mosby
-
(2003)
Comprehensive Clinical Nephrology
, pp. 243-253
-
-
Johnson, R.J.1
-
3
-
-
0032957969
-
Natural history and treatment of lupus nephritis
-
Austin, H.A. and Balow, J.E. (1999) Natural history and treatment of lupus nephritis. Semin. Nephrol. 19, 2-11
-
(1999)
Semin. Nephrol.
, vol.19
, pp. 2-11
-
-
Austin, H.A.1
Balow, J.E.2
-
4
-
-
0344492212
-
Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus
-
Baechler, E.C. et al. (2003) Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus. PNAS 1000, 2610-2615
-
(2003)
PNAS
, vol.1000
, pp. 2610-2615
-
-
Baechler, E.C.1
-
5
-
-
0348226819
-
Recent advances in the pathogenesis of lupus nephritis: Autoantibodies and B cells
-
Su, W. and Madaio, M.P. (2003) Recent advances in the pathogenesis of lupus nephritis: autoantibodies and B cells. Semin. Nephrol. 23, 564-568
-
(2003)
Semin. Nephrol.
, vol.23
, pp. 564-568
-
-
Su, W.1
Madaio, M.P.2
-
6
-
-
2542505506
-
The role of complement in the development of systemic lupus erythematosus
-
Manderson, A.P. et al. (2004) The role of complement in the development of systemic lupus erythematosus. Annu. Rev. Immunol. 22, 431-456
-
(2004)
Annu. Rev. Immunol.
, vol.22
, pp. 431-456
-
-
Manderson, A.P.1
-
7
-
-
0033538468
-
BLyS: Member of the tumor necrosis factor family and B lymphocyte stimulator
-
Moore, P.A. et al. (1999) BLyS: member of the tumor necrosis factor family and B lymphocyte stimulator. Science 285, 260-263
-
(1999)
Science
, vol.285
, pp. 260-263
-
-
Moore, P.A.1
-
8
-
-
0037247281
-
Newer drugs for the treatment of lupus nephritis
-
Kuiper-Geertsma, D.G. and Derksen, R.H. (2003) Newer drugs for the treatment of lupus nephritis. Drugs 63, 167-180
-
(2003)
Drugs
, vol.63
, pp. 167-180
-
-
Kuiper-Geertsma, D.G.1
Derksen, R.H.2
-
9
-
-
0034128373
-
ANCA glomerulonephritis and vasculitis: A Chapel Hill perspective
-
Falk, R.J. et al. (2000) ANCA glomerulonephritis and vasculitis: a Chapel Hill perspective. Semin. Nephrol. 20, 233-243
-
(2000)
Semin. Nephrol.
, vol.20
, pp. 233-243
-
-
Falk, R.J.1
-
10
-
-
0042570785
-
Neutrophil-activating potential of antineutrophil cytoplasmic autoantibodies
-
Rarok, A.A. et al. (2003) Neutrophil-activating potential of antineutrophil cytoplasmic autoantibodies. JLB 74, 3-15
-
(2003)
JLB
, vol.74
, pp. 3-15
-
-
Rarok, A.A.1
-
11
-
-
0036790387
-
Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice
-
Xiao, H. (2002) Antineutrophil cytoplasmic autoantibodies specific for myeloperoxidase cause glomerulonephritis and vasculitis in mice. JCI 110, 955-963
-
(2002)
JCI
, vol.110
, pp. 955-963
-
-
Xiao, H.1
-
12
-
-
1842508029
-
Autoimmunity is triggered by cPR-3 (105-201), a protein complementary to human autoantigen proteinase-3
-
Pendergraft, W.F. et al. (2004) Autoimmunity is triggered by cPR-3 (105-201), a protein complementary to human autoantigen proteinase-3. Nat Med. 10, 72-79
-
(2004)
Nat Med.
, vol.10
, pp. 72-79
-
-
Pendergraft, W.F.1
-
13
-
-
0035995335
-
Glomerular Remodeling: Novel therapeutic approaches derived from the apparently chaotic growth factor network
-
Floege, J. (2002) Glomerular Remodeling: novel therapeutic approaches derived from the apparently chaotic growth factor network. Nephron 91, 582-587
-
(2002)
Nephron
, vol.91
, pp. 582-587
-
-
Floege, J.1
-
14
-
-
0037217177
-
Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease
-
Kurogi, Y. (2003) Mesangial cell proliferation inhibitors for the treatment of proliferative glomerular disease. Med. Res. Rev. 23, 15-31
-
(2003)
Med. Res. Rev.
, vol.23
, pp. 15-31
-
-
Kurogi, Y.1
-
15
-
-
0042388115
-
A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis
-
Huang, Y. et al. (2003) A mutant, noninhibitory plasminogen activator inhibitor type 1 decreases matrix accumulation in experimental glomerulonephritis. JCI 112, 379-388
-
(2003)
JCI
, vol.112
, pp. 379-388
-
-
Huang, Y.1
-
16
-
-
0038717407
-
BMP-7 counteracts TGF-β-induced epithelial-to-mesenchymal transition and reverses chronic renal injury
-
Zeisberg, M. et al. (2003) BMP-7 counteracts TGF-β-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat. Med. 9, 964-968
-
(2003)
Nat. Med.
, vol.9
, pp. 964-968
-
-
Zeisberg, M.1
-
17
-
-
0742288423
-
Make or break for costimulatory Blockers. News feature
-
Garber, K. (2004) Make or break for costimulatory Blockers. News feature. Nat. Biotechnol. 22, 145-147
-
(2004)
Nat. Biotechnol.
, vol.22
, pp. 145-147
-
-
Garber, K.1
-
18
-
-
0030781307
-
Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with roscovitine, a novel cyclin-dependent kinase antagonist
-
Pippin, J.W. et al. (1997) Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with roscovitine, a novel cyclin-dependent kinase antagonist. JCI 100, 2512-2520
-
(1997)
JCI
, vol.100
, pp. 2512-2520
-
-
Pippin, J.W.1
-
19
-
-
0242524381
-
Pentoxifylline in the treatment of refractory nephrotic syndrome secondary to lupus nephritis
-
Galindo-Rodriguez, G. et al. (2003) Pentoxifylline in the treatment of refractory nephrotic syndrome secondary to lupus nephritis. J. Rheumatol. 30, 2382-2384
-
(2003)
J. Rheumatol.
, vol.30
, pp. 2382-2384
-
-
Galindo-Rodriguez, G.1
-
20
-
-
0037638841
-
Rituximab therapy and autoimmune disorders
-
Silverman, G.J. and Weisman, S. (2003) Rituximab therapy and autoimmune disorders. Arthritis Rheum. 48, 1484-1492
-
(2003)
Arthritis Rheum.
, vol.48
, pp. 1484-1492
-
-
Silverman, G.J.1
Weisman, S.2
-
21
-
-
0037315004
-
Complement inhibition in renal disease
-
Inal, J.M. et al. (2003) Complement inhibition in renal disease. Nephrol. Dial. Transplant. 18, 237-240
-
(2003)
Nephrol. Dial. Transplant.
, vol.18
, pp. 237-240
-
-
Inal, J.M.1
-
22
-
-
0028084439
-
Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis
-
Tang, W.W. et al. (1994) Interleukin-1 receptor antagonist ameliorates experimental anti-glomerular basement membrane antibody-associated glomerulonephritis. JCI 93, 273-279
-
(1994)
JCI
, vol.93
, pp. 273-279
-
-
Tang, W.W.1
-
23
-
-
0033883903
-
Clinical and biologic effects of anti-interleukin-10 monocloncal antibody administration in systemic lupus erythematosus
-
Llorente, L. et al. (2000) Clinical and biologic effects of anti-interleukin-10 monocloncal antibody administration in systemic lupus erythematosus. Arthritis Rheum. 43, 1790-1800
-
(2000)
Arthritis Rheum.
, vol.43
, pp. 1790-1800
-
-
Llorente, L.1
-
24
-
-
0033136794
-
Endothelial expression of VCAM-1 in experimental crescentic nephritis and effect of antibodies to very late antigen-4 or VCAM-1 on glomerular injury
-
Allen, A.R. et al. (1999) Endothelial expression of VCAM-1 in experimental crescentic nephritis and effect of antibodies to very late antigen-4 or VCAM-1 on glomerular injury. J. Immunol. 162, 5519-5527
-
(1999)
J. Immunol.
, vol.162
, pp. 5519-5527
-
-
Allen, A.R.1
-
25
-
-
0025277164
-
Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1
-
Border, W. A. et al. (1990) Suppression of experimental glomerulonephritis by antiserum against transforming growth factor beta 1. Nature 346, 371-374
-
(1990)
Nature
, vol.346
, pp. 371-374
-
-
Border, W.A.1
-
26
-
-
0038188724
-
Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F(1) mice
-
Kinoshita, K. et al. (2003) Retinoic acid reduces autoimmune renal injury and increases survival in NZB/W F(1) mice. J. Immunol. 170, 5793-5798
-
(2003)
J. Immunol.
, vol.170
, pp. 5793-5798
-
-
Kinoshita, K.1
-
27
-
-
0031940491
-
Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease
-
Zoja, C. et al. (1998) Bindarit retards renal disease and prolongs survival in murine lupus autoimmune disease. KI 53, 726-734
-
(1998)
KI
, vol.53
, pp. 726-734
-
-
Zoja, C.1
|